Ucwaningo lubonisa ukuthi ukudla amaprotheni ezitshalo amaningi kusiza ekwandiseni impilo, ukukhuphuka kwamaprotheni ezitshalo, kunciphise ukuguga kwezinto eziphilayo, futhi ukufaka amaprotheni ezilwane esikhundleni samaprotheni ezitshalo nakho kuhlotshaniswa nokubambezeleka ukuguga.

Ngaphezu kwalokho, ukuhlobana phakathi kwamaprotheni ezitshalo nokuguga kwezinto eziphilayo kuxhunyaniswa ngokwengxenye yi-serum GGT, ALT, kanye ne-AST.

Ocwaningweni, abacwaningi bahlaziye ababambiqhaza abangama-79,294 kusizindalwazi sase-UK Biobank, isilinganiso seminyaka engama-56, ama-47% abesilisa, baqoqa imininingwane yezokudla ngohlu lwemibuzo, futhi bahlola amaprotheni ezitshalo, ukudla kwamaprotheni ezilwane, futhi bahlaziya ubudlelwano phakathi kwamaprotheni ezitshalo nokudla kwamaprotheni ezilwane kanye nokuguga kwezinto eziphilayo.

Imiphumela yabonisa ukuthi ukudla okuphezulu kwamaprotheni ezitshalo kwakuhlobene kabi ne-HKDM-BA, HPA ne-HAL, futhi kuhlotshaniswa kahle ne-LTL.

Ngokukhethekile, labo abadla kakhulu amaprotheni ezitshalo bahlotshaniswa ne-17%, 14%, 10% yezinkinga eziphansi ze-HKDM-BA, HPA, HAL, kanye nezingqinamba eziphakeme ezingu-6% ze-LTL uma kuqhathaniswa nalabo abathatha kancane amaprotheni ezitshalo.

Ngokuqondana nje, ngoJanuwari 2024, Abacwaningi esikhungweni sokucwaninga sokuguga soMnyango Wezolimo wase-US, i-Harvard University, bashicilele isihloko ku-American Journal of Clinical Nutrition enesihloko esithi "Ukudla kwamaprotheni e-midlife maqondana nemiphumela yokuguga enempilo.

Ucwaningo lubonise ukuthi ukudla kwamaprotheni asekelwe ezitshalweni kuhlotshaniswa nempilo ende enempilo, nalabo abadla amaprotheni amaningi asekelwe ezitshalweni eminyakeni ephakathi babe namathuba angama-46% okuphila impilo ende futhi enempilo eminyakeni yakamuva kunalabo abadla kancane, futhi ukwanda kwamagremu angu-10 weprotheyini esekelwe ezitshalweni ngosuku kwakuhlotshaniswa nethuba elikhuphukile elingu-35% lokuphila impilo ende nenempilo.

?